RM
VIRX
RP Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,700
| Closed | -$74 | – | 4 |
|
|
2025
Q1 | $74 | Hold |
3,700
| – | – | ﹤0.01% | 4 |
|
|
2024
Q4 | $851 | Hold |
3,700
| – | – | ﹤0.01% | 4 |
|
|
2024
Q3 | $851 | Hold |
3,700
| – | – | ﹤0.01% | 4 |
|
|
2024
Q2 | $2K | Hold |
3,700
| – | – | ﹤0.01% | 4 |
|
|
2024
Q1 | $3.77K | Hold |
3,700
| – | – | ﹤0.01% | 3 |
|
|
2023
Q4 | $2.11K | Hold |
3,700
| – | – | ﹤0.01% | 3 |
|
|
2023
Q3 | $3.85K | Hold |
3,700
| – | – | ﹤0.01% | 3 |
|
|
2023
Q2 | $5.22K | Hold |
3,700
| – | – | 0.01% | 3 |
|
|
2023
Q1 | $5.88K | Hold |
3,700
| – | – | 0.01% | 3 |
|
|
2022
Q4 | $5.4K | Hold |
3,700
| – | – | 0.01% | 3 |
|
|
2022
Q3 | $16K | Hold |
3,700
| – | – | 0.01% | 3 |
|
|
2022
Q2 | $18K | Hold |
3,700
| – | – | 0.01% | 4 |
|
|
2022
Q1 | $18K | Hold |
3,700
| – | – | 0.01% | 4 |
|
|
2021
Q4 | $13.5M | Hold |
3,700
| – | – | 5.65% | 4 |
|
|
2021
Q3 | $30K | Hold |
3,700
| – | – | 0.01% | 3 |
|
|
2021
Q2 | $42K | Hold |
3,700
| – | – | 0.02% | 3 |
|
|
2021
Q1 | $34K | Sell |
3,700
-125,817
| -97% | -$1.16M | 0.01% | 4 |
|
|
2020
Q4 | $26K | Hold |
129,517
| – | – | 0.01% | 4 |
|
|
2020
Q3 | $16K | Hold |
129,517
| – | – | ﹤0.01% | 5 |
|
|
2020
Q2 | $34K | Hold |
129,517
| – | – | 0.01% | 5 |
|
|
2020
Q1 | $53K | Hold |
129,517
| – | – | 0.02% | 5 |
|
|
2019
Q4 | $44K | Hold |
129,517
| – | – | 0.01% | 5 |
|
|
2019
Q3 | $93K | Hold |
129,517
| – | – | 0.06% | 4 |
|
|
2019
Q2 | $95K | Hold |
129,517
| – | – | 0.06% | 4 |
|
|
2019
Q1 | $158K | Hold |
129,517
| – | – | 0.08% | 4 |
|
|
2018
Q4 | $54K | Buy |
+129,517
| New | +$54K | 0.04% | 4 |
|